Duration of antiviral immunity after smallpox vaccination
- PMID: 12925846
- DOI: 10.1038/nm917
Duration of antiviral immunity after smallpox vaccination
Abstract
Although naturally occurring smallpox was eliminated through the efforts of the World Health Organization Global Eradication Program, it remains possible that smallpox could be intentionally released. Here we examine the magnitude and duration of antiviral immunity induced by one or more smallpox vaccinations. We found that more than 90% of volunteers vaccinated 25-75 years ago still maintain substantial humoral or cellular immunity (or both) against vaccinia, the virus used to vaccinate against smallpox. Antiviral antibody responses remained stable between 1-75 years after vaccination, whereas antiviral T-cell responses declined slowly, with a half-life of 8-15 years. If these levels of immunity are considered to be at least partially protective, then the morbidity and mortality associated with an intentional smallpox outbreak would be substantially reduced because of pre-existing immunity in a large number of previously vaccinated individuals.
Comment in
-
Keeping the lock on smallpox.Nat Med. 2003 Sep;9(9):1115-6. doi: 10.1038/nm0903-1115. Nat Med. 2003. PMID: 12949522 No abstract available.
Similar articles
-
Antiviral immunity following smallpox virus infection: a case-control study.J Virol. 2010 Dec;84(24):12754-60. doi: 10.1128/JVI.01763-10. Epub 2010 Oct 6. J Virol. 2010. PMID: 20926574 Free PMC article.
-
Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.J Infect Dis. 2004 Oct 1;190(7):1286-94. doi: 10.1086/423848. Epub 2004 Aug 30. J Infect Dis. 2004. PMID: 15346340 Clinical Trial.
-
The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.Clin Microbiol Infect. 2007 Jan;13(1):91-3. doi: 10.1111/j.1469-0691.2006.01576.x. Clin Microbiol Infect. 2007. PMID: 17184294
-
Immunity and immunological memory following smallpox vaccination.Immunol Rev. 2006 Jun;211:320-37. doi: 10.1111/j.0105-2896.2006.00392.x. Immunol Rev. 2006. PMID: 16824139 Review.
-
[Jenner's cowpox vaccine in light of current vaccinology].Verh K Acad Geneeskd Belg. 1996;58(5):479-536; discussion 537-8. Verh K Acad Geneeskd Belg. 1996. PMID: 9027132 Review. Dutch.
Cited by
-
Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.NPJ Vaccines. 2022 Oct 19;7(1):120. doi: 10.1038/s41541-022-00542-5. NPJ Vaccines. 2022. PMID: 36261460 Free PMC article.
-
Immune modulation in primary vaccinia virus zoonotic human infections.Clin Dev Immunol. 2012;2012:974067. doi: 10.1155/2012/974067. Epub 2011 Dec 20. Clin Dev Immunol. 2012. PMID: 22229039 Free PMC article.
-
Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China.Emerg Infect Dis. 2024 Feb;30(2):321-324. doi: 10.3201/eid3002.230542. Emerg Infect Dis. 2024. PMID: 38270156 Free PMC article.
-
CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans.J Immunol. 2013 Jun 15;190(12):6023-33. doi: 10.4049/jimmunol.1202523. Epub 2013 May 10. J Immunol. 2013. PMID: 23667112 Free PMC article.
-
Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020.Emerg Infect Dis. 2021 Apr;27(4):1007-14. doi: 10.3201/eid2704.203569. Emerg Infect Dis. 2021. PMID: 33756100 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
